FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 332:536-538 February 23, 1995 Number 8 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Serruys, P. W. Related Article by Fischman, D. L. PubMed Citation

To the Editor: The Benestent¹ and Stent Restenosis (STRESS)² studies (Aug. 25 issue) raise important questions about strategies for coronary-stent placement. Should coronary stents be considered for all patients with new focal lesions in large coronary arteries that have a high likelihood of dissection,³ or should they be used only on a conditional basis if balloon angioplasty does not achieve the desired degree of dilation?

Although the randomized studies^1,2 showed that coronary-stent placement reduced the rate of clinical restenosis, the only component of the composite end point that was favorably affected was the need for a second intervention involving the . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Ribault, S., Neuville, P., Mechine-Neuville, A., Auge, F., Parlakian, A., Gabbiani, G., Paulin, D., Calenda, V. (2001). Chimeric Smooth Muscle-Specific Enhancer/Promoters : Valuable Tools for Adenovirus-Mediated Cardiovascular Gene Therapy. Circ. Res. 88: 468-475 [Abstract] [Full Text]